U.S. FDA Approves Welireg (belzutifan) Plus Lenvima (lenvatinib) for Certain Previously Treated Adult Patients With Advanced Renal Cell Carcinoma With a Clear Cell Component (ccRCC)

Sep 28, 2026 - 03:00
 0  0
RAHWAY, N.J. & NUTLEY, N.J.--(BUSINESS WIRE) September 25, 2026 -- Merck (NYSE: MRK), known as MSD outside of the United States and Canada, and Eisai today announced the U.S. Food and Drug Administration (FDA) has approved the dual oral...

What's Your Reaction?

Like Like 0
Dislike Dislike 0
Love Love 0
Funny Funny 0
Angry Angry 0
Sad Sad 0
Wow Wow 0